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Abstract
Introduction: E-cadherin (E-cad; cadherin 1) and N-cadherin (N-cad; cadherin 2) are the most prominent members
of the cadherin family of cell adhesion molecules. Although they share many structural and functional features,
they are expressed in an almost mutually exclusive manner in vivo.
Methods: To explore functional differences between the two cadherins in vivo, we recently generated a knock-in
line in which N-cad is expressed from the E-cad locus. In combination with a conditional gene inactivation
approach, we expressed N-cad in the absence of E-cad (referred to as Ncadk.i.) in alveolar epithelial cells of the
mammary gland starting in late pregnancy.
Results: We found that the sole presence of N-cad induces constitutively active fibroblast growth factor (Fgf)
signaling and a precocious involution resulting in massive apoptosis of alveolar cells. To block apoptosis, we
conditionally deleted one allele of p53 in Ncadk.i. mice and observed a temporal rescue of alveolar morphology
and function. However, an accumulation of fibrotic tissue and cysts with increasing age and lactation cycles was
observed. This phenotype closely resembled fibrocystic mastopathy (FM), a common disorder in humans, which is
thought to precede breast cancer. Concordantly, 55% of Ncadk.i. mice harboring a heterozygous p53 deletion
developed malignant and invasive tumors.
Conclusions: Our results demonstrate a possible role for N-cad in the formation of fibrosis and cysts in the
mammary gland. Moreover, we show that these lesions precede the development of malignant tumors. Thus, we
provide a new mouse model to investigate the molecular mechanisms of fibrocystic mastopathy and the transition
from benign to malignant tumors.
Introduction
Classical cadherins are cell adhesion molecules, which
play fundamental roles in the development of multicel-
lular organisms [1]. E-cadherin (E-cad, Cdh1) is the
founding member of the cadherin gene family and is
essential for the integrity of epithelial tissues. The first
epithelial cell layer in the development of mouse
embryos, the trophectoderm of blastocysts, requires E-
cad for proper function. In later embryonic stages and
in adult organisms, E-cad also provides adhesive
strength to form polarized epithelial cell layers [2]. N-
cadherin (N-cad, Cdh2) is initially expressed at the
gastrulation stage when epiblast cells downregulate E-
cad and undergo an epithelial-mesenchymal transition
(EMT). This process includes the upregulation of N-cad
in the nascent mesoderm. In later stages and in adults,
N-cad is restricted to neural tissue and cells of
mesenchymal origin [3]. Thus, in vivo, both cadherins
are often expressed in a mutually exclusive manner. E-
cad and N-cad share many structural and functional fea-
tures. Both establish calcium-dependent homophilic cell-
cell adhesion with their extracellular domains and are
connected with catenins at their intracellular domains
[4]. E-cad and N-cad have been shown to be able to
interact with the receptors of different growth factors,
which suggests that cadherins are involved in the modu-
lation of signaling pathways. For example, E-cad associ-
ates with receptors of epidermal growth factors (EGFR)
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any medium, provided the original work is properly cited.[5], whereas N-cad interacts with receptors of fibroblast
growth factors (FGFR) and thus modulates signaling
function [6]. We recently addressed the question of inter-
changeability of the two cadherins by generating a mouse
model in which N-cad cDNA was introduced into the E-
cad locus. In these mice, N-cad was efficiently expressed
in the E-cad expression domains. Homozygous N-cadk.i.
mutants fail to form a proper trophectoderm in blasto-
cysts, demonstrating that N-cad cannot replace E-cad in
early embryos [7]. However, in a conditional gene repla-
cement approach, we presented evidence that N-cad can
support epithelial integrity in the embryonic intestine,
but these mice showed a pathologic phenotype after birth
[8]. Here, we investigated the capacity of N-cad in sup-
porting epithelial integrity in the mammary gland of
a d u l tm i c e .T h em a m m a r yg l a n d( M G )c o n s i s t so f
lobulo-alveolar structures formed by epithelial cells
expressing E-cad [9]. Myoepithelial cells surround the
alveoli and provide mechanical stimuli to the epithelial
cells of the alveoli during the lactation process. Both
alveoli and myoepithelial cells are maintained by signals
derived from the stromal compartment [10]. To replace
E-cad with N-cad in the mouse mammary gland epithe-
lium, we applied the Ncadk.i. allele together with a condi-
tional E-cad allele [11]. The floxed E-cad allele was
ablated using WAP::Cre mice, which express Cre recom-
binase in the alveolar epithelium of the mammary gland
from late pregnancy on and during lactation [12]. We
found that the expression of N-cad in the absence of E-
cad induces precocious involution and ultimately p53-
mediated apoptosis in the alveoli. By conditional ablation
of one p53 allele, we could block apoptosis in the alveoli
and found that the tissue integrity and function of the
alveoli was completely rescued. However, in aged mice
and after numerous lactation cycles, we noticed increased
fibrosis accompanied by cyst formation, which ultimately
led to a loss of lactation capacity. Finally, we observed a
transition from these benign lesions to malignant and
highly invasive tumors.
Materials and methods
Mouse lines and genotyping
The generation of WAP::Cre [12], Ecad
Ncad/+ [7], Ecad
fl/
fl [11] and p53









fl/fl lines were mated with p53
fl/fl animals to





fl/+ genotype, respectively. Experi-
mentation with mice was performed according to §4
German Animal Welfare Law and after review by the
Institutional Animal Care and Use Committee (IACUC),
internal license #KE-iTO-6.
Genotyping was performed by PCR with genomic
DNA isolated from mouse tail biopsies using primers
for the Ncad k.i.a l l e l e( 5 ’-CCAAGAACTTCTGCTA-
GAC-3’ and 5’-TGGCAACTTGTCTAGGGA-3’)[7],
Ecad wt and floxed allele (5’-CTTATACCGCTCGA-
GAGCCGGA-3’)( 5 ’-GTGTCCCTCCAAATCCGATA-
3’) [11] and p53 floxed allele (5’-CTACCTGAAGAC-
CAAGAAGG-3’)( 5 ’-TGGAGGATATGGACCCTATG-
3’)[14]. The WAP::Cre transgene was detected using the
following primers (5’-TAGAGCTGTGCCAGCCT
CTTC-3’)a n d( 5 ’-CATCACTCGTTGCATCG ACC-3’)
[12].
Histology
Whole mount staining of inguinal mammary glands was
performed as previously described [15]. Briefly, mam-
mary glands were fixed for 2 to 4 hours in Carnoy’s
fixative (6 parts 100% ethanol, 3 parts chloroform, 1
part acetic acid). The fixed glands were de-fatted in
acetone for 2 hours, stained with carmine solution dur-
ing the night, and rinsed in tap water. After dehydration,
the samples were embedded in paraffin and photo-
graphed with a Nikon DXM1200f.
The left thoracic mammary glands were dissected,
fixed, dehydrated, embedded in paraffin, and sectioned
at 7 μm. Sections were dewaxed, rehydrated, and stained
with hematoxylin (#H3136) and eosin (#212954), Mas-
son trichome (#HT15), and Oil Red O [16] (#O0625, all
from Sigma Aldrich, München Germany). The stained
paraffin slides were photographed with a Zeiss Axiocam.
Immunohistochemistry, immunofluorescence, and
antibodies
Immunohistochemistry (IHC) on paraffin sections of the
thoracic mammary gland was performed as described
previously [17]. The following antibodies were used.
Mouse anti-N-cadherin (#610921), mouse monoclonal
anti-E-cadherin (#610182), mouse anti-Stat3 (#610189,
all from BD Transduction Laboratories, Heidelberg, Ger-
many). Affinity-purified rabbit anti-gp84 antibody
against the extracellular domain of E-cadherin [18],
anti-Vimentin monoclonal antibody (#11-254-C100,
Exbio/HiSS, Freiburg, Germany,), mouse monoclonal
anti-p53 (#PAb421, Enzo, Lörrach, Germany. Rabbit
monoclonal anti-Stat5 antibody (,#9358), anti-Erk1/2
antibody (#9102), anti-cleaved Caspase 3 (#9664s), anti-
phospho-Erk1/2 antibody (#9101), rabbit monoclonal
anti-phospho-Stat3 antibody (#9145, all from Cell Sig-
naling/NEB, Frankfurt, Germany), Anti-CFTR antibody
(#SC-10747), anti-WAP antibody (#SC-14832), anti-
Snail1 antibody (#SC-10433), anti-MTA1 (#SC-10813,
all from Santa Cruz, Heidelberg, Germany). Monoclonal
anti N-cadherin (#C3865, Sigma Aldrich, München,
Germany), anti-PCNA (#M0879, Dako, Hamburg,
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body (#CB1001, all from Calbiochem/Merck, Darmstadt,
Germany).
For mouse and rabbit antibodies, the DAKO Envision
+ System HRP was used to amplify the signals (#K4000
and #K4002, DakoCytomation, Hamburg, Germany). For
rat and goat antibodies, secondary peroxidase-conju-
gated anti-rat and anti-goat IgG antibodies (Jackson
ImmunoResearch Laboratories, West Grove, USA) were
used, respectively. Staining of paraffin sections was
visualized with DAB Peroxidase Substrate (#D-4293,
Sigma, München, Germany). For immunofluorescence,
secondary fluorochrome-conjugated antibodies
(Alexa488 and 583) were used (Molecular Probes/Invi-
trogene, Darmstadt, Germany). The stained paraffin
slides were photographed with a Axiocam (Zeiss, Göt-
tingen, Germany) and SP2 UV (Leica, Wetzlar,
Germany).
Western blot analysis
The preparation of protein extracts for Western Blot
analysis has been described previously [19]. Briefly, 2 mg
of fresh or frozen tissue was homogenized on ice in 2
ml of lysis buffer (#R0891, Fermentas, St. Leon-Rot,
Germany) including the phosphatase inhibitor phenyl-
methyl sulfonyl fluoride (#10837091001, Roche, Man-
nheim, Germany) and protease inhibitors (Complete,
#11836153001, Roche, Mannheim, Germany). The
lysates were cleared by centrifugation at 14,000 g for 10
minutes at 4°C, subjected to SDS-PAGE, and transferred
to a Polyvinylidenfluorid (PVDF) membrane. Mem-
branes were probed with primary antibodies. Specific
binding was detected with horseradish-peroxidase
(HRP)-conjugated secondary antibodies (Jackson Immu-
noResearch Laboratories, We s tG r o v e ,U S A )a n dv i s u a -
lized with ECL Plus (#RNP2132, Amersham/GE
Healthcare, Freiburg, Germany,).
In vitro organ culture
For application of the Fgf inhibitor SU5402 (#572630,
Calbiochem/Merck, Darmstadt, Germany).
mammary glands were isolated and transferred in
DMEM medium (#41966, Invitrogen, Darmstadt, Ger-
many) in the absence of serum, either supplemented
with 40 μM SU5402 dissolved in dimethyl sulfoxide
(DMSO) or the corresponding amount of DMSO as a
control. After 24 hours of incubation at 37°C and 10%
CO2 the tissue was treated as described above.
Results
N-cadk.i. mice lose lactation capacity
As a first approach, the different mutant and control
mice were examined for their lactation capacity. For
this, pups were weighed each day, starting at the day of
birth. Pups from WAP::Cre;Ecad
fl/+ (referred to as con-
trol) females gained weight progressively until the end
of the lactation period at day 18. The end of lactation
was followed by the transition to solid food uptake and
was accompanied by a transient stagnation of body
weight (Additional File 1). In contrast, pups from WAP::
Cre;Ecad
Ncad/fl (referred to as Ncadk.i.) females died two
to three days after birth. We could not detect any signs
of milk in the stomach of these pups, indicating that
lactation was impaired before the offspring were born
(data not shown). WAP::Cre;Ecad
fl/fl (referred to as
Ecadk.o.) females also showed a defect in lactation capa-
city. In contrast to Ncadk.i., the mother could feed the
offspring for the first ten days and the pups gained
weight comparable to control mice. Then, the lactation
stopped and the offspring died within two to three days
(Additional File 1A). Interestingly, Ncadk.i. females
showed a more severe phenotype in comparison to
Ecadk.o. animals, as measured by the lactation capacity.
This result may indicate that the effects observed in
Ncadk.i. mice did not originate from the lack of E-cad.
Rather, the presence of N-cad may account for the
severe decrease in lactation capacity. For controls, pups
were exchanged between Ncadk.i., Ecadk.o., and control
animals. Pups of Ncadk.i. and Ecadk.o. mutant females
survived and developed normally when fed by control
females. Conversely, when pups of control mice were
placed with mutant mothers, the pups lost weight pro-
gressively and died (data not shown). These results
clearly demonstrate that the cause of death is the incap-
ability of Ncadk.i. mutant mice to nurse the offspring.
The morphology of Ncadk.i. and Ecadk.o. mammary
glands is highly disturbed
Since the recombination efficiency of the WAP::Cre line
increases substantially in the second lactation cycle
compared to the first (data not shown [12]), we per-
formed the analyses of the mammary glands (MG) at
the third day of the second lactation cycle. Figure 1
shows MG from Ncadk.i., Ecadk.o., and control animals.
In each case, the left anterior thoracic MG was taken
for comparison. Whole mount carmine staining revealed
that the MG from Ncadk.i. and Ecadk.o. were smaller in
size and contained fewer lobulo-alveolar structures as
compared to controls (Figure 1, upper panel and Addi-
tional File 1B). H&E staining of tissue sections revealed
that the morphology of Ncadk.i. and Ecadk.o. MG was
highly disturbed (Figure 1). Both Ncadk.i. and Ecadk.o.
showed collapsed alveolar structures. The recombination
activity of WAP::Cre was monitored by introducing a
ROSA26 reporter allele [20]. Whole mount X-Gal stain-
ing and sections demonstrated the efficient Cre recom-
bination activity in mutant and control samples
resulting in highly decreased E-cad levels in mutants
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Page 3 of 16Figure 1 The morphology of Ncadk.i. and Ecadk.o. mammary glands is profoundly disturbed. Carmine whole mount staining of Ncadk.i.
and Ecadk.o. mammary glands revealed size differences (upper panel) and reduction of lobulo-alveolar structures compared to the controls (see
insets in the upper panel). Cre recombination activity was visualized using a ROSA26 reporter and demonstrated the efficiency of the WAP::Cre
transgenic line in whole mount X-Gal staining and sections. In H&E-stained sections, the collapsed lobulo-alveolar structures in mutants became
apparent. Ncadk.i. mammary glands also showed pronounced accumulation of fibrous tissue around the collapsed alveoli (arrows). Scale bars:
Carmine: 1 mm; Carmine insets and X-gal whole mount: 3 mm; sections: 100 μm. Control, WAP::Cre;Ecad
fl/+ ; Ecadk.o., WAP::Cre;Ecad
fl/fl ; H&E:
hematoxylin and eosin; Ncadk.i., WAP::Cre;Ecad
Ncad/fl ; ROSA26: reverse orientation splice acceptor 26; WAP::Cre: Whey acidic protein::Cre.
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Page 4 of 16(Figure 1, lower panel, Additional File 2). Immunohisto-
logical analysis of Ncadk.i. MG revealed a mislocaliza-
tion of N-cad at the luminal site of epithelial cells in
collapsed alveoli (Figure 2A). In comparison, intact
alveoli of control MG showed E-cad at the basolateral
site of alveolar epithelial cells (Figure 2A). Interestingly,
the remaining intact alveoli in Ecadk.o. MG were nega-
tive for E-cad (Figure 2A). This observation suggests
that the lack of E-cad did not immediately lead to the
collapse of all alveolar structures. In contrast, the com-
plete alveolar architecture was affected in Ncadk.i. MG.
The comparative immunohistological analyses are in
agreement with the different lactation capacities of
Ncadk.i. and Ecadk.o. reported above. Whey acidic pro-
tein (WAP), a component of the milk and a marker for
milk productivity, was completely absent in Ncadk.i. and
decreased in Ecadk.o. compared to control (Figure 2A,
B). Surprisingly, Phospho-Stat3 (p-Stat3), a key player in
the involution process [21], is strongly activated in
Ncadk.i. alveolar epithelial cells. In contrast, Ecadk.o.
and the control did not show the activation of this invo-
lution marker (Figure 2A, B). In accordance with the
activation of p-Stat3, its downstream components p53
and cleaved caspase3 (which initiate the involution pro-
cess) are highly activated in Ncadk.i. MG (Figure 2B).
Remarkably, p53 is also activated in Ecadk.o MG,
although p-Stat3 is not detectable. These data may indi-
cate that p53 can be activated by different pathways.
Deletion of one p53 allele rescues the lactation capacity
of Ncadk.i. but not of Ecadk.o. females
Downstream events of Stat3-mediated involution include
p53-dependent apoptosis of epithelial cells in the MG.
Conditional heterozygous deletion of p53 was performed
by introducing p53 floxed alleles in Ncadk.i., Ecadk.o,
and control females to eventually block the precocious
involution observed in Ncadk.i. MG (Additional File 3).
Strikingly, Ncadk.i. mice carrying only one intact allele
of p53 (WAP::Cre;Ecad
Ncad/fl;p53
fl/+, referred to as
Ncadk.i.;p53) exhibited a lactation capacity comparable
to control mice (WAP::Cre;Ecad
fl/+;p53
fl/+, referred to as
control;p53) (Additional File 4A). In contrast, the lacta-
tion capacity of Ecadk.o.;p53 females (WAP::Cre;Ecad
fl/fl;
p53
fl/+) was not rescued by the deletion of one p53 allele
(Additional File 4A). The morphologies of MG from
Ncadk.i.;p53 and control;p53 animals on the third day of
the second lactation cycle visualized by carmine staining
were remarkably similar (Figure 3A). Both showed well-
developed lobulo-alveolar structures. In contrast, Ecadk.
o.;p53 exhibited few lobulo-alveolar structures (Figure
3A and Additional File 4B). H&E staining of sections
from Ncadk.i.;p53 MG showed normal tissue integrity,
similar to the control. In contrast, in Ecadk.o.;p53, the
lobulo-alveolar structure appeared collapsed, leaving
clusters of epithelial cords with small lumina (Figure
3A, arrowheads).
From these results, we concluded that removal of one
p53 allele is beneficial for the function and morphology
of Ncadk.i. MG. Immunostaining revealed that N-cad
was properly localized at the basolateral site of the MG
epithelium, comparable to E-cad in control;p53 (Figure
3B). Milk production, visualized by WAP staining, was
fully functional in Ncadk.i.;p53 and control;p53, whereas
Ecadk.o.;p53 MG did not exhibit the presence of WAP
(Figure 3B).
Intriguingly, we detected high levels of p-Stat3 in
Ncadk.i.;p53 MG. P-Stat3 is known to initiate the invo-
lution process by activating p53-dependent apoptosis in
wild type MG (Figure 3C). The absence of apoptosis in
Ncadk.i.;p53 MG indicates that p53 acts downstream of
p-Stat3 signaling and is central in controlling the apop-
totic process in involution. Moreover, the action of p53
in involution seems to be highly dosage-dependent
because apoptosis was avoided by the deletion of only
one p53 allele in Ncadk.i.;p53 MG. In contrast, the het-
erozygous deletion of p53 in Ecadk.o. mice could not
rescue the Ecadk.o. phenotype.
Ncadk.i. and Ncadk.i.;p53 females develop fibrosis and
cysts in the MG with increasing lactation cycles
Hematoxylin and eosin staining of Ncadk.i. (Figure 1,
arrows) and Ncadk.i.;p53 (Figure 3A, arrows) already
suggested increased fibrotic accumulations in the MG.
To further investigate this phenomenon, we performed
Trichrome staining. Indeed, in the second lactation
cycle, Ncadk.i. and Ncadk.i.;p53 MG showed an accu-
mulation of blue-stained collagenic fibers around col-
lapsed and intact alveoli (Figure 4A and 4B). With
increasing lactation cycles, the accumulation of fibrotic
tissue became increasingly apparent and predominant.
After 10 lactation cycles (Figure 4A and 4B), fibrotic
tissue appeared to displace the alveolar morphology in
Ncadk.i.;p53 MG, which ultimately led to impaired lac-
tation. No increased fibrosis was observed in Ecadk.o.
and Ecadk.o.;p53 mice, nor in controls (Figure 4A and
4B). Fibrosis is often accompanied by the formation of
cyst-like structures, which is only observed in Ncadk.i.
and Ncadk.i.;p53 animals (Figure 5). Cysts became
apparent in Ncadk.i.;p53 several lactation cycles earlier
as compared to Ncadk.i. animals. These observations
indicate that N-cad may have an inductive role in cyst
formation that is enhanced by the lack of p53. Cystic
fibrosis transmembrane conductance regulator (CFTR)
is an ABC transporter-class ion channel that transports
chloride and thiocyanate ions across epithelial cell
membranes. Mutations of the CFTR gene in humans
affect functioning of the chloride ion channels in cell
membranes, leading to cystic fibrosis [22,23]. In
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Page 5 of 16Figure 2 Ncadk.i. mammary glands exhibit signs of precocious involution. (A) Immunofluorescence of paraffin sections revealed a
mislocalization of N-cad in collapsed alveoli of Ncadk.i. mammary glands. No E-cad could be detected in Ecadk.o. alveoli, which looked
morphologically normal. In control samples, E-cad but not N-cad, could be found at the basolateral site of alveolar epithelial cells. DAPI was used
to visualize nuclei of the cells. The alveoli of Ecadk.o. females show immunoreactivity for WAP while WAP is completely absent in Ncadk.i. alveoli.
P-Stat3, a key player in the involution process, is highly upregulated in Ncadk.i., whereas Ecadk.o. and control did not show any signal for p-
Stat3. Scale bar: 100 μm. (B) Western Blot analysis of mammary glands on the second day of the second lactation cycle. WAP is highly
decreased in Ecadk.o. and completely absent in Ncadk.i. mammary glands compared to control. P-Stat3 is induced in Ncadk.i., indicating
involution. P53, an inducer of apoptosis, is highly upregulated in Ncadk.i. and Ecadk.o.; however, cleaved caspase3 was predominantly detected
in Ncadk.i. mammary glands. GAPDH was used to ensure the loading of equal amounts of proteins. Control, WAP::Cre;Ecad
fl/+ ; DAPI, 4’,6-
diamidino-2-phenylindole; E-cad, E-cadherin; Ecadk.o., WAP::Cre;Ecad
fl/fl; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; N-cad, N-cadherin;
Ncadk.i., WAP::Cre;Ecad
Ncad/fl;p53, protein 53; P-Stat3, Phospho Signal transducer and activator of transcription 3; WAP, Whey acidic protein.
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Page 6 of 16Figure 3 Morphology and function of Ncadk.i.;p53 mammary glands are comparable to control samples. (A) Whole mount carmine
staining of Ncadk.i.;p53 mammary glands showed comparable lobulo-alveolar structures to control;p53, while Ecadk.o.;p53 mammary glands
possess only poorly developed structures. This observation was confirmed by H&E-stained paraffin sections showing intact alveoli in Ncadk.i.;p53
and control;p53 mammary glands and collapsed lobulo-alveolar structures in Ecadk.o.;p53 mammary glands (arrowheads). The accumulation of
fibrous tissue surrounding the alveoli in Ncadk.i.;p53 was still present (arrows). Scale bar: Carmin: 3 mm; H&E: 100 μm (B) Immunofluorescence on
paraffin sections revealed basolateral localization of N-cad in the alveoli of Ncadk.i.p53 mammary glands, resembling E-cad staining in control;p53
samples. DAPI was used to visualize the nuclei in Ecadk.o.;p53 sections, which were negative for E-cad. The detection of WAP was used to verify
the function of the alveoli. Ncadk.i.p53 and control;p53 showed similar WAP levels, while Ecadk.o.p53 exhibited highly decreased levels. Scale bar:
100 μm (C) Western Blot analysis of Ncadk.i.p53, Ecadk.o.;p53, and control;p53 mammary gland lysates. Notably, Ncadk.i.p53 shows a constitutive
activation of p-Stat3. control;p53, WAP::Cre; Ecad
fl/+; DAPI, 4’,6-diamidino-2-phenylindole; E-cad, E-cadherin; Ecadk.o.;p53, WAP::Cre;Ecad
fl/fl;p53
fl/+;
H&E, Hematoxylin and Eosin; N-cad, N-cadherin; Ncadk.i.;p53, WAP::Cre;Ecad
Ncad/fl;p53
fl/+; p53
fl/+; WAP, Whey acidic protein.
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Page 7 of 16Figure 4 Accumulation of fibrous tissue in the mammary gland of Ncadk.i. and Ncadk.i.;p53 mice. Trichrome staining of paraffin sections
was used to visualize the accumulation of fibrous tissue in (A) Ncadk.i. and (B) Ncadk.i.;p53 mammary glands in the second and tenth lactation
cycles. The pronounced deposit of collagen fibers in the second lactation cycle became markedly increased in females after ten lactation cycles.
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Page 8 of 16addition, CFTR is required in intestinal Caco cells for
proper lipid transport through the cell membranes
[24,25]. In control;p53 MG, CFTR is expressed
throughout the alveolar epithelial cells (Figure 5).
However, in Ncadk.i. and Ncadk.i.;p53, CFTR expres-
sion is greatly reduced, which may perturb lipid secre-
tion as visualized by Oil Red staining (Figure 5). Lipid
droplets were found accumulated in alveolar epithelial
cells of Ncadk.i. and Ncadk.i;p53 MG, but not in con-
trol;p53 (Figure 5) or in Ecadk.o. and Ecadk.o.;p53 MG
(data not shown). From these results, we concluded
that cyst formation is accompanied by reduced CFTR
levels in the MG of Ncadk.i. and Ncadk.i.;p53 as
observed in human cystic fibrosis. However, whether
the lack of CFTR contributes directly to the formation
of cysts needs to be elucidated.
Alveolar epithelial cells of the MG in Ncadk.i. mice
upregulate markers for epithelial-mesenchymal transition
(EMT) and gain migratory properties
By tracing recombined cells with the ROSA26 reporter
allele, we frequently observed alveolar epithelial cells
leaving the epithelial cell layer and accumulating in the
stroma in Ncadk.i. and Ncadk.i.;p53 females with
advanced lactation cycles (Figure 6A). These data sug-
gested that alveolar epithelial cells in Ncadk.i. and
Ncadk.i.;p53 MG undergo epithelial-mesenchymal tran-
sition (EMT) to gain migratory properties. This idea was
Figure 5 Cyst formation in Ncadk.i. and Ncadk.i.;p53 mammary glands. With increasing lactation cycles, the accumulation of fibrous tissue
was accompanied by the formation of cysts. After ten lactation cycles, H&E-stained paraffin sections showed cyst formation in both Ncadk.i. and
Ncadk.i.;p53 mammary glands, while no cysts were observed in controls. Premalignant marks, such as calcification (arrows) and accumulation of
necrotic material (arrowheads), were detected in both lines. Cyst formation was accompanied by a downregulation of CFTR. Oil Red staining
showed the accumulation of lipids in alveolar epithelial cells in Ncadki. and Ncadk.i;p53 mammary glands. Scale bar: 100 μm. CFTR, Cystic Fibrosis
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Page 9 of 16Figure 6 Ncadk.i. alveolar epithelial cells exhibit signs of epithelial-mesenchymal transition (EMT). (A) The ROSA26 reporter allele was
used to trace recombined alveolar epithelial cells. LacZ expression, visualized by X-gal staining, indicates Cre activity which normally is restricted
to alveolar epithelial cells as shown in the control;p53 sample. Many LacZ-positive epithelial cells in Ncadk.i. and Ncadk.i.;p53 mammary glands
changed their cell shape, migrated outside the alveoli, and were found in the stromal compartment. This process was accompanied by the
activation of p-Erk and the upregulation of Snail1. Scale bar: 100 μm. (B) Western Blot analysis revealed the upregulation of the mesenchymal
marker Vimentin in Ncadk.i. and Ncadk.i.;p53 mammary glands. Notably, Vimentin, but not Snail, is also upregulated in Ecadk.o. and Ecadk.o.;p53.
GAPDH was used for the loading control. control;p53, WAP::Cre; Ecad
fl/+; Ncadk.i., WAP::Cre;Ecad
Ncad/fl; GAPDH, Glyceraldehyde 3-phosphate
dehydrogenase; Ncadk.i.;p53, WAP::Cre;Ecad
Ncad/fl;p53
fl/+; p-Erk, phospho-extracellular signal-regulated kinase; ROSA26, reverse orientation splice
acceptor 26; X-gal, 5-bromo-4-chloro-indolyl-galactopyranoside.
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Page 10 of 16supported by the fact that the mesenchymal marker
Vimentin was highly upregulated in the MG of these
mice (Figure 6B). Transcription factors of the Snail
family have been shown to be essential for the initiation
of EMT. We found Snail1 induced in epithelial cells of
Ncadk.i. and Ncadk.i.;p53 MG (arrowheads in Figure
6A), whereas no Snail1 was detected in control samples
(Figure 6A and 6B). Since Snail1 is a direct target of Fgf
signaling [26,27], we examined the phosphorylation sta-
tus of Fgf receptor 1 (Fgfr1) as well as the downstream
effector of Fgf signaling, Erk. Active Fgf signaling
marked by phosphorylated Fgfr1 (p-Fgfr1) was found in
Ncadk.i. and Ncadk.i;p53 MG (Additional File 5).
Accordingly, phosphorylated Erk (p-Erk) was also
detected in these tissues (Figure 6A arrows,F i g u r e6 B ) .
Whereas control samples showed a complete lack of
active Fgf signaling, Ecadk.o. and Ecadk.o.;p53 MG exhi-
bit moderate p-Erk levels in the absence of p-Fgfr (Fig-
ure 6B and Additional File 5). These data suggest that
N-cad plays an inductive role in turning on the Fgf sig-
naling pathway in Ncadk.i. and Ncadk.i.;p53 MG. To
obtain further evidence for these results we performed
in vitro organ culture. Freshly isolated Ncadk.i.;p53 MG
were treated with a Fgf signaling inhibitor, SU5402
which inhibits specifically the tyrosin kinase activity of
Fgfr1 [28]. A corresponding amount of DMSO was used
as a control. As expected, the protein levels of p-Stat3,
p-Erk and Snail1 were reduced upon SU5402 treatment
compared with the control confirming our in vivo obser-
vation (Additional File 6). Interestingly, the detection of
EMT markers and the observation of increased motility
of alveolar epithelial cells happened in a temporally dis-
tinct manner. Snail and p-Erk were found even in early
lactation cycles, but migratory epithelial cells were only
visible from the eighth lactation cycle onwards (not
shown). These data may indicate that alveolar epithelial
cells require additional stimuli to achieve migratory
properties. Ecadk.o. and Ecadk.o.;p53 MG do not show
any migrating alveolar cells (Additional File 7). This sug-
gests that the lack of E-cad in alveolar epithelial cells is
not sufficient to induce EMT and gain migratory
properties.
Transition from benign to malignant structures and
tumor formation
In aged Ncadk.i and Ncadk.i.;p53 mice with numerous
lactation cycles, we observed a histological transition
from benign to malignant structures. These structures
included calcification (Figure 5, arrows), accumulation
of necrotic material inside the cysts (Figure 5, arrow-
heads), ductal ectasia, lymphocytic ductitis, and ductal
hyperplasia (data not shown). Large tumors were
observed in the left thoracic mammary gland of Ncadk.i.
and Ncadk.i.;p53 females (Figure 7A, arrows). In
Figure 7 Ncadk.i. and Ncadk.i.;p53 females develop malignant
and highly invasive tumors. (A) Ncadk.i. and Ncadk.i.;p53 females
developed large tumors (arrows) after numerous lactation cycles
that were always found in the left thoracic mammary gland. (B)
H&E staining of tumor sections revealed poorly differentiated cells.
X-gal staining identified many transformed alveolar epithelial cells,
which contribute to the tumor structure. Immunohistochemistry on
paraffin sections revealed that tumor cells are highly proliferative,
indicated by PCNA staining, and express high levels of p-Erk, Sox2,
and the metastatic marker MTA1. Scale bar: 100 μm (C) X-gal
staining traced alveolar epithelial cells derived from the tumor in
the axillary lymph node, demonstrating the metastatic capacity of
the tumor cells. No LacZ-positive cells were found in control lymph
nodes. Scale bar: 100 μm. (D) Heterozygous deletion of p53
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suppression, increased tumor incidence was found in
Ncadk.i;p53 (five out of nine) as compared to Ncadk.i.
(one out of ten) animals (Figure 7D). The reduction of
p53 also decreases the time of tumor onset in Ncadk.i.
mice (Figure 7D). Strikingly, Ecadk.o., Ecadk.o.;p53, and
WAP::Cre;p53 females did not show tumor formation
even in aged mice (data not shown). Histological analysis
of tumors from Ncadk.i.;p53 animals showed poorly dif-
ferentiated cells and a sarcoma-like morphology (Figure
7B, upper left panel). Many cells in the tumor were posi-
tive for LacZ, indicating that these cells are transformed
alveolar epithelial cells that contribute to the tumor.
Moreover, Proliferating cell nuclear antigene (PCNA)
staining revealed that nearly all of the cells were in a pro-
liferative state (Figure 7B). As shown above, we supposed
that p-Erk signaling initiated EMT in alveolar epithelial
cells. We found many cells inside the tumor that still
maintained p-Erk signaling, suggesting that this pathway
supports tumor growth (Figure 7B). Sox2 has been
shown to be involved in breast tumorigenesis [29]. We
detected abundant Sox2 expression in the tumor (Figure
7B). In addition, we found extensive staining for metasta-
sis-associated protein 1 (MTA1). Expression of MTA1
has been correlated with metastatic potential in two
types of carcinomas [30,31] (Figure 7B). In line with the
high expression of MTA1, we found LacZ-positive cells
in the left axillary lymph node of tumor-afflicted mice
(Figure 7C). These data clearly demonstrate that epithe-
lial cells of the mammary gland are transformed and
highly invasive in Ncadk.i.;p53 mice. Interestingly, no
tumors were observed in Ecadk.o.;p53 or WAP::Cre p53,
even in females with numerous lactation cycles (data not
shown). Although the pivotal role of p53 in involution
and tumor formation has been reported previously
[32,33], these results demonstrate the synergistic poten-
tial of N-cad together with p53 in promoting tumor for-
mation in the mammary gland.
Discussion
The morphology and function of lobulo-alveolar struc-
tures in the mammary gland are highly dependent on
the expression of E-cad [34]. Female mammary glands
deficient for E-cad lose milk productivity and exhibit
collapsed lobulo-alveolar structures with signs of prema-
ture involution and apoptosis [11]. According to these
results, E-cad has been proposed to be a survival factor
for the epithelial cells of the mammary gland [11]. To
explore the specific functions of E-cad in comparison to
N-cad in vivo, we made use of a knock-in mouse line in
which N-cad is expressed under the regulatory control
of the E-cad locus [7]. In our approach, we combined
the Ncadk.i. line with the conditional ablation of the
remaining E-cad allele. We directed the conditional
ablation to the alveoli of the mammary gland using
WAP::Cre, which efficiently recombined the remaining
E-cad floxed allele starting at the late pregnancy stage.
In the first part of our study, we analyzed the lactation
capacity of Ncadk.i., Ecadk.o., and control animals and
found some unexpected results. From our previous
work [11], we had anticipated that the Ecadk.o. mice
would exhibit a more drastic phenotype, and we had
hoped that the presence of the Ncadk.i. allele would be
beneficial for the structure and function of the mam-
mary gland. But the opposite is the case, in that com-
plete feeding impairment was observed only in Ncadk.i.
mice. The fact that Ecadk.o. females can nurse their off-
spring for about 10 days may be explained by the rela-
tive late induction of Cre expression by WAP::Cre,
compared to the early Cre expression in the MMTV::
Cre transgenic line, which was used previously [11]. In
addition, the known stability of the E-cad protein may
preserve some alveolar structures even when the E-cad
floxed allele is already recombined. In this respect we
analyzed tight junctional proteins as Occludin and ZO1
which may account for the stabilization of the epithelial
cell layer in the absence of E-cad. However, both factors
are found to be more weakly expressed and mislocalized
(data not shown). This is in line with previous reports
which found that E-cad regulates tight junctional com-
plexes in epithelial cells [35]. Histological analysis of
Ncadk.i. mammary glands revealed collapsed lobular-
alveolar structures, a feature which resembles the invo-
lution process. Indeed, we found that p-Stat3, an involu-
tion marker, was induced in Ncadk.i. MG. In contrast,
p-Stat3 was not upregulated in Ecadk.o. alveoli, indicat-
ing that the involution program was not immediately
triggered despite elevated levels of p53. Rather, the sole
expression of N-cad induced precocious involution. Our
results differ from those of a previous report where a
transgenic mouse was generated to overexpress N-cad
in the mammary gland epithelium in the presence of E-
cad [36]. In these mice the mammary glands appeared
normal and no tumors arose spontaneously. Accord-
ingly, Ncadk.i./+ mice do not show any abnormality and
develop normally [7]. In comparison to our results this
enhances the tumorigenic potential of N-cad. At least nine animals
were analyzed for tumor incidence and tumor onset. Ten percent of
Ncadk.i. mice develop mammary tumors. This number increases to
more than 50% upon additional heterozygous deletion of p53 (left
panel). The average age of tumor onset is decreased in Ncadk.i.;p53
compared to Ncadk.i. mice (right panel). H&E, Hematoxylin and
Eosin; MTA1, Metastatic tumor antigen1; Ncadk.i., WAP::Cre;Ecad
Ncad/
fl; Ncadk.i.;p53, WAP::Cre; Ecad
Ncad/fl;p53
fl/+; p53, protein 53; p-Erk,
phospho-extracellular signal-regulated kinase; Sox2, SRY (sex
determining region Y)-box 2; X-gal, 5-bromo-4-chloro-indolyl-
galactopyranoside.
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taining tissue integrity and its tumor suppressor func-
tion, even in the presence of N-cad. In addition this
shows that E-cad can neutralize the action of N-cad in
MG epithelial cells in vivo, an observation which was
made before in cancer cell lines [37].
Stat3 is the key player in the involution process [21].
Its activation depends mainly on receptor tyrosine
kinase (RTK) signaling, in particular, on the Fgf signal-
ing pathway [26,38]. Fgf signaling has previously been
shown to be able to be activated by the physical interac-
tion of N-cad and Fgf receptor in vitro [39]. Our in vivo
results are in agreement with these observations, as
Ncadk.i MG showed high levels of p-Fgfr, p-Erk, and
the upregulation of Fgf target genes like Stat3 and
Snail1. At the onset of involution, p-Stat3 is known to
induce the upregulation of pro-apoptotic factors, such
as p53, in mammary glands [40]. Thus, we performed
heterozygous deletion of p53 to eventually interfere with
the precocious involution and apoptosis. Surprisingly,
the deletion of one p53 allele completely rescued the
lobulo-alveolar structure and the lactation capacity of
Ncadk.i. mice, but not of Ecadk.o. mice. This result is
remarkable considering the unique role of E-cad and the
interaction with the epidermal growth factor receptor,
which has been proposed to be essential for mammary
gland function [41,42]. Here we show that N-cad can
replace E-cad as an adhesion molecule for the integrity
of the mammary epithelial cell layer for at least 5 lacta-
tion cycles. However, the adhesion function of N-cad
becomes apparent only if the p53 level is reduced.
These data suggest that the functions of cadherins and
p53 are closely linked. Furthermore, the data show the
pivotal role of p53 in regulating the balance between
apoptosis and proliferation in a highly dosage-dependent
manner. A 50% reduction of p53 was sufficient to rescue
the cells from apoptosis. The expression of N-cad
shifted this balance towards apoptosis, most likely due
to the activation of the Fgf pathway. The constitutive
activation of Fgf signaling may also be the cause of the
increased fibrosis and cyst formation that is observed in
Ncadk.i. mice after several lactation cycles. The forma-
tion of cysts is closely associated with fibrotic processes
[43]. We suppose that increased fibrosis in the mam-
mary gland imposes mechanical pressure on ducts and
alveoli which then results in cyst formation. The patho-
logical phenotype of our mice closely resembles fibro-
cystic mastopathy (FM), which is a common human
disorder affecting 30% to 60% of the world’s female
population [44]. FM is characterized by a massive accu-
mulation of fibrous tissue at the interstitial spaces and
the formation of cysts [45]. Mutations in the CFTR gene
have been shown to promote FM [23]. Interestingly,
previous results have suggested that p-Erk mediates the
downregulation of CFTR expression [46]. The activation
of p-Erk signaling, accompanied by CFTR downregula-
tion, is observed in the mouse model shown here, sug-
gesting an important role for Fgf signaling in FM. CFTR
has profound effects on lipid metabolism [47], and its
downregulation is implicated in increased lipid synthesis
and accumulation in intestinal Caco cells [24]. Similarly,
the loss of CFTR in our mice resulted in lipid accumula-
tion in mammary epithelial cells.
In addition, our mouse model showed premalignant
features as reported for FM, including calcifications
inside the alveoli [48], collagen fiber deposition [49],
lymphocytic infiltrations, and ductal hyperplasia [50].
The transition from benign to malignant structures in
our mouse model is potentiated by the heterozygous
p53 deletion, which is in accordance with the well-estab-
lished role of p53 as a tumor suppressor [51]. The fact
that Ecadk.o., Ecadk.o.;p53, and WAP::Cre;p53 females
did not show any tumor formation may be explained by
the genetic background of the mice used in this study
which is predominantly C57Bl6. This strain has been
shown to have a significantly lower susceptibility to
mammary tumorigenesis compared to other inbred
strains in particular Balb/c [52,53]. Furthermore, it
becomes evident that temporal and spatial differences of
conditional approaches play a pivotal role. For example,
the conditional deletion of p53 and E-cad in alveolar
progenitor cells leads to invasive lobular carcinoma [13],
whereas mature alveolar cells do not show any onco-
genic transformation lacking p53 and E-cad as seen in
our approach. A prerequisite for the development of
invasive tumors is that epithelial cells undergo EMT,
which is a process in which epithelial cells lose cell
adhesion contacts, upregulate mesenchymal genes, and
gain cell motility [54]. EMT plays fundamental roles in
the development and metastasis of epithelial tumors
[55]. Using ROSA26 reporter mice, we were able to
trace alveolar epithelial cells. We clearly show that many
cells in Ncadk.i.;p53 mammary glands leave the epithe-
lial cell cluster and migrate through the stroma. On the
molecular level, we have detected the upregulation of
several genes that are implicated in EMT, including
Vimentin, Snail1 and p-Erk [56]. Snail1 binds to E-
Boxes of the E-cad promoter and induces the downregu-
lation of E-cad [57]. N-cad expression from the Ncadk.i.
allele should also be affected since it is driven by the
endogenous E-cad promoter. So far, we could not deter-
mine the upregulation of endogenous N-cad which is
another important event in EMT in the transformed
cells because the discrimination between endogenous
and knocked-in N-cad mRNA is technically challenging.
EMT is most likely initiated in alveolar epithelial cells of
t h eN c a d k . i .m i c eb yc o n s t i t u t i v eF g fs i g n a l i n g ,w h i c h
ultimately leads to the appearance of malignant tumors.
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expression of Sox2 and Stat3, which depend on Fgf sig-
naling [30,39], and of the metastasis associated protein
(MTA1), which is regulated by Stat3 [31]. Altogether,
these results provide compelling evidence that the
tumor initiating cells are transformed alveolar epithelial
cells that adopt a mesenchymal fate and form a sar-
coma-like tumor.
Conclusions
Our gene replacement approach demonstrates that N-
cad in the absence of E-cad induces constitutively active
Fgf signaling and premature involution, which results in
massive apoptosis of alveolar cells. Additional deletion
of one p53 allele inhibits the pro-apoptotic effect of N-
cad and leads to a temporal rescue of morphology and
function of alveoli. The deletion of E-cad also leads to
cell death of alveolar cells, however, this cannot be res-
cued by p53 deletion. This indicates that N-cad provides
the essential features to maintain tissue architecture and
function which implies fully overlapping function of E-
and N-cadherin in the alveoli. With increasing age and
lactation cycles, fibrosis and cysts are observed in N-
cadk.i. mammary glands resulting in the blockage of lac-
tation and finally the appearance of malignant tumors.
These effects are potentiated by the heterozygous dele-
tion of p53. The fact that no tumors are observed in
p53+/- nor in Ecad,p53 MG suggests a pivotal role of
N-cad in the development of breast tumors. Thereby we
show that the formation of fibrosis and cysts always pre-
cede the development of malignant tumors. Thus, the
stromal (fibrotic) compartment in the MG may provide
the essential stimuli for the transition of N-cad from its
adhesive to an oncogenic function. All these features of
our mouse model closely resemble FM in humans and
makes this model a valuable tool to investigate the
underlying molecular mechanism of fibrosis and cysts
and the transition to malignant tumors in the mammary
gland.
Additional material
Additional file 1: Ncadk.i. and Ecadk.o. females show impaired
lactation capacity and reduced number of intact alveoli. (A) To
evaluate the function of the mammary gland, the weight of the pups of
the corresponding females were monitored during the normal lactation
period at the second lactation cycle. Control pups (green graph) gained
weight progressively until reaching the time of weaning (approximately
20 days). Pups from Ecadk.o. females survived only 12 to 13 days (red
graph) whereas pups from Ncadk.i. females died only two to three days
after birth (blue graph). (B) The number of collapsed and intact alveoli
was quantified in six individual H&E stained paraffin MG sections of
Ncadk.i., Ecadk.o. and control mice from the third day of the second
lactation cycle. The percentage of collapsed (red) or intact (blue) alveoli
is depicted in relation to the entire amount of alveoli counted on the
section (= 100%). Ncadk.i., WAP::Cre;Ecad




Additional file 2: Protein expression levels of Ecad and Ncad in
Ncad.k.i. and Ncad.k.i.:p53 mammary glands. Western blot analysis of
mammary gland protein lysates shows highly reduced protein levels of
E-cad in both Ncad.k.i. and Ncad.k.i.:p53 animals as a result of efficient
Cre mediated recombination. Ncad is expressed comparable to wildtype





fl/+; N-cad, N-cadherin; GAPDH, Glyceraldehyde 3-phosphate
dehydrogenase.
Additional file 3: Heterozygous p53 deletion leads to a marked
decrease of active p53. Western blot analysis of mammary gland
protein lysate reveals a approximate 50% decrease of p53 protein level in





protein 53; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase.
Additional file 4: The heterozygous deletion of p53 rescues the
lactation capacity and the number of intact alveoli of Ncadk.i. but
not of Ecadk.o. females. (A) The weights of pups from Ncadk.i.;p53
females (blue graph) monitored during the first four weeks after birth
were comparable to the control (green), while the deletion of p53 in
Ecadk.o. females had no effect on the survival rate of the offspring (red).
(B) The number of collapsed and intact alveoli was quantified in six
individual H&E stained paraffin MG sections of Ncadk.i., Ncadk.i.;p53 and
control;p53 mice from the third day of the second lactation cycle. The
percentage of collapsed (red) or intact (blue) alveoli is depicted in
relation to the entire amount of alveoli counted on the section (= 100%).
Ncadk.i.;p53, WAP::Cre;Ecad
Ncad/fl;p53







Additional file 5: Fgf receptor activation is detected in Ncad.k.i. and
Ncad.k.i.:p53 but not in Ecad.k.o. nor Ecad.k.o.:p53 mammary
glands. Western blot analysis of mammary gland protein lysates reveals
the presence of p-Fgfr in both Ncad.k.i. and Ncad.k.i.:p53 mammary
glands whereas Ecad.k.o. and Ecad.k.o.:p53 were negative for p-Fgfr. Fgfr
and GAPDH were used as loading controls. p-Fgfr, phospho-Fibroblast





fl/fl ; Ecadk.o.;p53, WAP::Cre;
Ecad
fl/fl;p53
fl/+; Fgfr, Fibroblast growth factor receptor; GAPDH,
Glyceraldehyde 3-phosphate dehydrogenase.
Additional file 6: Blocking of the Fgf pathway in mammary gland
in-vitro organ culture induces down-regulation of downstream
factors. Ncad.k.i.:p53 mammary glands were incubated with either the
Fgf inhibitor SU5402 or DMSO as a control for 24 hours at 37°C.
Immunohistochemistry of tissue sections from these samples show a
downregulation of p-Stat3 upon SU5402 exposure compared to control.
Western blot analysis of protein lysates reveals the downregulation of p-
Stat3, p-Erk and Snail1 after the treatment with SU5402 compared to
control. GAPDH was used as a loading control. Ncadk.i.;p53, WAP::Cre;
Ecad
Ncad/fl;p53
fl/+; Fgf, Fibroblast growth factor; DMSO, Dimethylsulfoxid;
P-Stat3, phospho-Signal transducer and activator of transcription 3; p-Erk,
phospho-extracellular signal-regulated kinase; GAPDH, Glyceraldehyde 3-
phosphate dehydrogenase.
Additional file 7: Ecadk.o. and Ecadk.o.;p53 MG do not show any
migration of alveolar epithelial cells. Ecadk.o., Ecadk.o.;p53 and
control;p53 MG containing the ROSA26 allele were isolated at the
third day of the tenth lactation cycle. After whole mount X-gal
staining the MG were sectioned and counterstained. Recombined
alveolar epithelial cells do not migrate from the epithelial cell layer in the
three samples depicted. Ecadk.o., WAP::Cre;Ecad
fl/fl ; Ecadk.o.;p53, WAP::
Cre;Ecad
fl/fl;p53
fl/+; control;p53, WAP::Cre; Ecad
fl/+; p53
fl/+; ROSA26, reverse
orientation splice acceptor 26; X-gal, 5-bromo-4-chloro-indolyl-
galactopyranoside.
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fl/fl; E-cad: E-cadherin, epithelial cadherin; EMT: epithelial-
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Page 14 of 16mesenchymal transition; Erk: extracellular signal-regulated kinase; Fgf:
fibroblast growth factor; Fgfr: fibroblast growth factor receptor; FM:
fibrocystic mastopathy; GAPDH: glyceraldehyde 3-phosphate dehydrogenase;
H&E: hematoxylin and eosin; MMTV: mouse mammary tumor virus; MTA1:




Ncad/fl; N-cad: N-cadherin, neural cadherin; p53: protein 53 or
tumor protein p53; PCNA: proliferating cell nuclear antigen; p-Erk: p-Erk
phosphorylated active form of Erk; p-Stat3: phosphorylated active form of
Stat3; RTK: receptor tyrosine kinase; Sox2: SRY (sex determining region Y)-box
2; Stat3: signal transducer and activator of transcription 3; WAP: whey acidic
protein; X-gal: 5-bromo-4-chloro-indolylgalactopyranoside.
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